Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies (Q57226425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Herbert Kuster

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Michael Huber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Manuela Rehr

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Huldrych F Günthard

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

10

Annette Oxenius

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Peter Rusert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Beda Joos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Marek Fischer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Christine Leemann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Amapola Manrique

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Rainer Weber

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Gabriela Stiegler

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Brigitta Vcelar

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Hermann Katinger

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Leonardo Aceto

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

8 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

615-622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm1244

11 January 2020

exact match

0 references

cites work

Immunopathogenesis and immunotherapy in AIDS virus infections

1 reference

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

21 January 2018

1 reference

Role of neutralizing antibodies in HIV infection

21 January 2018

1 reference

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

21 January 2018

1 reference

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

21 January 2018

1 reference

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

21 January 2018

1 reference

Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies

21 January 2018

1 reference

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

21 January 2018

1 reference

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

21 January 2018

1 reference

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

21 January 2018

1 reference

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

21 January 2018

1 reference

Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant

21 January 2018

1 reference

Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

21 January 2018

1 reference

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

21 January 2018

1 reference

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1.

21 January 2018

1 reference

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation

21 January 2018

1 reference

Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma

21 January 2018

1 reference

Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection

21 January 2018

1 reference

A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120.

21 January 2018

1 reference

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

21 January 2018

1 reference

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

Present status of human HIV vaccine development

21 January 2018

1 reference

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

21 January 2018

1 reference

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

21 January 2018

1 reference

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

21 January 2018

1 reference

A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.

21 January 2018

1 reference

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

21 January 2018

1 reference

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

21 January 2018

1 reference

A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART.

21 January 2018

1 reference

HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse

21 January 2018

1 reference

Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission

21 January 2018

1 reference

Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol

21 January 2018

1 reference

Phase I Study of a Human Monoclonal Antibody Directed against the CD4-Binding Site of HIV Type 1 Glycoprotein 120

21 January 2018

1 reference

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

21 January 2018

1 reference

7 January 2021

Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection

1 reference

7 January 2021

Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12

1 reference

7 January 2021

Characterization of HIV-1 neutralization escape mutants

1 reference

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

7 January 2021

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

7 January 2021

Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?

1 reference

7 January 2021

Detection of low HIV-1 RNA levels in plasma

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15880120%20AND%20SRC:MED&resulttype=core&format=json